Markets

Market Nav

INCOME STATEMENT

You can view the income statement for the last 5 years.
Panacea Biotec Ltd.
( in Crs.)

ParticularsMar 25Mar 24Mar 23Mar 22Mar 21
Months1212121212
Source Of Info (AR = Annual Report, PR = Press Release)PRARARARAR
FaceValue1.001.001.001.001.00
      
      
INCOME     
Revenue From Operations [Net]559.09551.93456.92659.22617.65
Other Operating Revenues0.007.243.032.017.16
Total Operating Revenues559.09559.17459.95661.23624.81
      
Other Income20.6625.8051.6610.979.98
Total Revenue579.75584.96511.61672.20634.78
      
EXPENSES     
Cost Of Materials Consumed214.07210.46211.03281.25167.76
Purchase Of Stock-In Trade7.601.807.2629.9331.26
Changes In Inventories Of FG,WIP And Stock-In Trade-22.1317.8634.37-48.975.61
Employee Benefit Expenses173.05149.57126.48182.94156.17
Finance Costs3.883.584.44180.84185.34
Depreciation And Amortisation Expenses34.8136.7139.1243.6645.59
Other Expenses212.41199.54178.76229.95187.37
Total Expenses623.69619.52601.47899.60779.11
      
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax-43.94-34.56-89.86-227.40-144.32
      
Exceptional Items35.9936.03102.661676.210.00
Profit/Loss Before Tax-7.951.4812.811448.81-144.32
      
Tax Expenses-Continued Operations     
Current Tax0.770.692.56400.732.32
Deferred Tax0.002.2943.99-29.82-0.37
Total Tax Expenses0.772.9846.55370.911.96
Profit/Loss After Tax And Before ExtraOrdinary Items-8.72-1.51-33.751077.90-146.28
      
Profit/Loss From Continuing Operations-8.72-1.51-33.751077.90-146.28
      
Profit/Loss From Discontinuing Operations0.000.000.000.00-0.78
Total Tax Expenses Discontinuing Operations0.000.000.000.000.67
Net Profit/Loss From Discontinuing Operations0.000.000.000.00-1.46
Profit/Loss For The Period-8.72-1.51-33.751077.90-147.74
      
Minority Interest0.350.330.51-0.02-0.04
Share Of Profit/Loss Of Associates0.000.000.000.000.08
Consolidated Profit/Loss After MI And Associates-8.37-1.17-33.241077.89-147.70
      
OTHER INFORMATION     
      
EARNINGS PER SHARE     
Basic EPS (Rs.)-1.37-0.19-5.43175.98-24.11
Diluted EPS (Rs.)-1.37-0.19-5.43175.98-24.11
ParticularsMar 25
Months12
Source Of Info (AR = Annual Report, PR = Press Release)PR
FaceValue1.00
  
INCOME 
Revenue From Operations [Net]559.09
Other Operating Revenues0.00
Total Operating Revenues559.09
Other Income20.66
Total Revenue579.75
EXPENSES 
Cost Of Materials Consumed214.07
Purchase Of Stock-In Trade7.60
Changes In Inventories Of FG,WIP And Stock-In Trade-22.13
Employee Benefit Expenses173.05
Finance Costs3.88
Depreciation And Amortisation Expenses34.81
Other Expenses212.41
Total Expenses623.69
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax-43.94
Exceptional Items35.99
Profit/Loss Before Tax-7.95
Tax Expenses-Continued Operations 
Current Tax0.77
Deferred Tax0.00
Total Tax Expenses0.77
Profit/Loss After Tax And Before ExtraOrdinary Items-8.72
Profit/Loss From Continuing Operations-8.72
Profit/Loss From Discontinuing Operations0.00
Total Tax Expenses Discontinuing Operations0.00
Net Profit/Loss From Discontinuing Operations0.00
Profit/Loss For The Period-8.72
Minority Interest0.35
Share Of Profit/Loss Of Associates0.00
Consolidated Profit/Loss After MI And Associates-8.37
OTHER INFORMATION 
EARNINGS PER SHARE 
Basic EPS (Rs.)-1.37
Diluted EPS (Rs.)-1.37